Anti-thrombin III Testing
Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that ina ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Bronchiectasis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Antibiotics 1.2.3 Expectorants 1.2.4 Other drugs 1.3 Market by Application 1.3.1 Global Bronchiectasis Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Research institute 1.3.4 Clinic 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Bronchiectasis Drugs Market Perspective (2016-2027) 2.2 Bronchiectasis Drugs Growth Trends by Regions 2.2.1 Bronchiectasis Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Bronchiectasis Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Bronchiectasis Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Bronchiectasis Drugs Industry Dynamic 2.3.1 Bronchiectasis Drugs Market Trends 2.3.2 Bronchiectasis Drugs Market Drivers 2.3.3 Bronchiectasis Drugs Market Challenges 2.3.4 Bronchiectasis Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Bronchiectasis Drugs Players by Revenue 3.1.1 Global Top Bronchiectasis Drugs Players by Revenue (2016-2021) 3.1.2 Global Bronchiectasis Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Bronchiectasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Bronchiectasis Drugs Revenue 3.4 Global Bronchiectasis Drugs Market Concentration Ratio 3.4.1 Global Bronchiectasis Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Drugs Revenue in 2020 3.5 Bronchiectasis Drugs Key Players Head office and Area Served 3.6 Key Players Bronchiectasis Drugs Product Solution and Service 3.7 Date of Enter into Bronchiectasis Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Bronchiectasis Drugs Breakdown Data by Type 4.1 Global Bronchiectasis Drugs Historic Market Size by Type (2016-2021) 4.2 Global Bronchiectasis Drugs Forecasted Market Size by Type (2022-2027) 5 Bronchiectasis Drugs Breakdown Data by Application 5.1 Global Bronchiectasis Drugs Historic Market Size by Application (2016-2021) 5.2 Global Bronchiectasis Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Bronchiectasis Drugs Market Size (2016-2027) 6.2 North America Bronchiectasis Drugs Market Size by Type 6.2.1 North America Bronchiectasis Drugs Market Size by Type (2016-2021) 6.2.2 North America Bronchiectasis Drugs Market Size by Type (2022-2027) 6.2.3 North America Bronchiectasis Drugs Market Size by Type (2016-2027) 6.3 North America Bronchiectasis Drugs Market Size by Application 6.3.1 North America Bronchiectasis Drugs Market Size by Application (2016-2021) 6.3.2 North America Bronchiectasis Drugs Market Size by Application (2022-2027) 6.3.3 North America Bronchiectasis Drugs Market Size by Application (2016-2027) 6.4 North America Bronchiectasis Drugs Market Size by Country 6.4.1 North America Bronchiectasis Drugs Market Size by Country (2016-2021) 6.4.2 North America Bronchiectasis Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Bronchiectasis Drugs Market Size (2016-2027) 7.2 Europe Bronchiectasis Drugs Market Size by Type 7.2.1 Europe Bronchiectasis Drugs Market Size by Type (2016-2021) 7.2.2 Europe Bronchiectasis Drugs Market Size by Type (2022-2027) 7.2.3 Europe Bronchiectasis Drugs Market Size by Type (2016-2027) 7.3 Europe Bronchiectasis Drugs Market Size by Application 7.3.1 Europe Bronchiectasis Drugs Market Size by Application (2016-2021) 7.3.2 Europe Bronchiectasis Drugs Market Size by Application (2022-2027) 7.3.3 Europe Bronchiectasis Drugs Market Size by Application (2016-2027) 7.4 Europe Bronchiectasis Drugs Market Size by Country 7.4.1 Europe Bronchiectasis Drugs Market Size by Country (2016-2021) 7.4.2 Europe Bronchiectasis Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Bronchiectasis Drugs Market Size (2016-2027) 8.2 Asia-Pacific Bronchiectasis Drugs Market Size by Type 8.2.1 Asia-Pacific Bronchiectasis Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Bronchiectasis Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Bronchiectasis Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Bronchiectasis Drugs Market Size by Application 8.3.1 Asia-Pacific Bronchiectasis Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Bronchiectasis Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Bronchiectasis Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Bronchiectasis Drugs Market Size by Region 8.4.1 Asia-Pacific Bronchiectasis Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Bronchiectasis Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Bronchiectasis Drugs Market Size (2016-2027) 9.2 Latin America Bronchiectasis Drugs Market Size by Type 9.2.1 Latin America Bronchiectasis Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Bronchiectasis Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Bronchiectasis Drugs Market Size by Type (2016-2027) 9.3 Latin America Bronchiectasis Drugs Market Size by Application 9.3.1 Latin America Bronchiectasis Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Bronchiectasis Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Bronchiectasis Drugs Market Size by Application (2016-2027) 9.4 Latin America Bronchiectasis Drugs Market Size by Country 9.4.1 Latin America Bronchiectasis Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Bronchiectasis Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Bronchiectasis Drugs Market Size (2016-2027) 10.2 Middle East & Africa Bronchiectasis Drugs Market Size by Type 10.2.1 Middle East & Africa Bronchiectasis Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Bronchiectasis Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Bronchiectasis Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Bronchiectasis Drugs Market Size by Application 10.3.1 Middle East & Africa Bronchiectasis Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Bronchiectasis Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Bronchiectasis Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Bronchiectasis Drugs Market Size by Country 10.4.1 Middle East & Africa Bronchiectasis Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Bronchiectasis Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Endo International Plc 11.1.1 Endo International Plc Company Details 11.1.2 Endo International Plc Business Overview 11.1.3 Endo International Plc Bronchiectasis Drugs Introduction 11.1.4 Endo International Plc Revenue in Bronchiectasis Drugs Business (2016-2021) 11.1.5 Endo International Plc Recent Development 11.2 GlaxoSmithKline Plc 11.2.1 GlaxoSmithKline Plc Company Details 11.2.2 GlaxoSmithKline Plc Business Overview 11.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Introduction 11.2.4 GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2016-2021) 11.2.5 GlaxoSmithKline Plc Recent Development 11.3 Neopharma LLC 11.3.1 Neopharma LLC Company Details 11.3.2 Neopharma LLC Business Overview 11.3.3 Neopharma LLC Bronchiectasis Drugs Introduction 11.3.4 Neopharma LLC Revenue in Bronchiectasis Drugs Business (2016-2021) 11.3.5 Neopharma LLC Recent Development 11.4 Pfizer Inc. 11.4.1 Pfizer Inc. Company Details 11.4.2 Pfizer Inc. Business Overview 11.4.3 Pfizer Inc. Bronchiectasis Drugs Introduction 11.4.4 Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2016-2021) 11.4.5 Pfizer Inc. Recent Development 11.5 Reckitt Benckiser Group Plc 11.5.1 Reckitt Benckiser Group Plc Company Details 11.5.2 Reckitt Benckiser Group Plc Business Overview 11.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Introduction 11.5.4 Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2016-2021) 11.5.5 Reckitt Benckiser Group Plc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Bronchiectasis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Antibiotics Table 3. Key Players of Expectorants Table 4. Key Players of Other drugs Table 5. Global Bronchiectasis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Bronchiectasis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Bronchiectasis Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Bronchiectasis Drugs Market Share by Regions (2016-2021) Table 9. Global Bronchiectasis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Bronchiectasis Drugs Market Share by Regions (2022-2027) Table 11. Bronchiectasis Drugs Market Trends Table 12. Bronchiectasis Drugs Market Drivers Table 13. Bronchiectasis Drugs Market Challenges Table 14. Bronchiectasis Drugs Market Restraints Table 15. Global Bronchiectasis Drugs Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Bronchiectasis Drugs Market Share by Players (2016-2021) Table 17. Global Top Bronchiectasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Drugs as of 2020) Table 18. Ranking of Global Top Bronchiectasis Drugs Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Bronchiectasis Drugs Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Bronchiectasis Drugs Product Solution and Service Table 22. Date of Enter into Bronchiectasis Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million) Table 25. Global Bronchiectasis Drugs Revenue Market Share by Type (2016-2021) Table 26. Global Bronchiectasis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Bronchiectasis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Bronchiectasis Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Bronchiectasis Drugs Revenue Market Share by Application (2016-2021) Table 30. Global Bronchiectasis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Bronchiectasis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million) Table 33. North America Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million) Table 35. North America Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Bronchiectasis Drugs Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Bronchiectasis Drugs Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Bronchiectasis Drugs Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Bronchiectasis Drugs Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Bronchiectasis Drugs Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Bronchiectasis Drugs Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Bronchiectasis Drugs Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Bronchiectasis Drugs Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Bronchiectasis Drugs Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Bronchiectasis Drugs Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Bronchiectasis Drugs Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Bronchiectasis Drugs Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Bronchiectasis Drugs Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Bronchiectasis Drugs Market Size by Country (2022-2027) & (US$ Million) Table 62. Endo International Plc Company Details Table 63. Endo International Plc Business Overview Table 64. Endo International Plc Bronchiectasis Drugs Product Table 65. Endo International Plc Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million) Table 66. Endo International Plc Recent Development Table 67. GlaxoSmithKline Plc Company Details Table 68. GlaxoSmithKline Plc Business Overview Table 69. GlaxoSmithKline Plc Bronchiectasis Drugs Product Table 70. GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million) Table 71. GlaxoSmithKline Plc Recent Development Table 72. Neopharma LLC Company Details Table 73. Neopharma LLC Business Overview Table 74. Neopharma LLC Bronchiectasis Drugs Product Table 75. Neopharma LLC Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million) Table 76. Neopharma LLC Recent Development Table 77. Pfizer Inc. Company Details Table 78. Pfizer Inc. Business Overview Table 79. Pfizer Inc. Bronchiectasis Drugs Product Table 80. Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million) Table 81. Pfizer Inc. Recent Development Table 82. Reckitt Benckiser Group Plc Company Details Table 83. Reckitt Benckiser Group Plc Business Overview Table 84. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Table 85. Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2016-2021) & (US$ Million) Table 86. Reckitt Benckiser Group Plc Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Bronchiectasis Drugs Market Share by Type: 2020 VS 2027 Figure 2. Antibiotics Features Figure 3. Expectorants Features Figure 4. Other drugs Features Figure 5. Global Bronchiectasis Drugs Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Research institute Case Studies Figure 8. Clinic Case Studies Figure 9. Other Case Studies Figure 10. Bronchiectasis Drugs Report Years Considered Figure 11. Global Bronchiectasis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Bronchiectasis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Bronchiectasis Drugs Market Share by Regions: 2020 VS 2027 Figure 14. Global Bronchiectasis Drugs Market Share by Regions (2022-2027) Figure 15. Global Bronchiectasis Drugs Market Share by Players in 2020 Figure 16. Global Top Bronchiectasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Drugs as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Bronchiectasis Drugs Revenue in 2020 Figure 18. Global Bronchiectasis Drugs Revenue Market Share by Type (2016-2021) Figure 19. Global Bronchiectasis Drugs Revenue Market Share by Type (2022-2027) Figure 20. North America Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Bronchiectasis Drugs Market Share by Type (2016-2027) Figure 22. North America Bronchiectasis Drugs Market Share by Application (2016-2027) Figure 23. North America Bronchiectasis Drugs Market Share by Country (2016-2027) Figure 24. United States Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Bronchiectasis Drugs Market Share by Type (2016-2027) Figure 28. Europe Bronchiectasis Drugs Market Share by Application (2016-2027) Figure 29. Europe Bronchiectasis Drugs Market Share by Country (2016-2027) Figure 30. Germany Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Bronchiectasis Drugs Market Share by Type (2016-2027) Figure 38. Asia-Pacific Bronchiectasis Drugs Market Share by Application (2016-2027) Figure 39. Asia-Pacific Bronchiectasis Drugs Market Share by Region (2016-2027) Figure 40. China Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Bronchiectasis Drugs Market Share by Type (2016-2027) Figure 48. Latin America Bronchiectasis Drugs Market Share by Application (2016-2027) Figure 49. Latin America Bronchiectasis Drugs Market Share by Country (2016-2027) Figure 50. Mexico Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Bronchiectasis Drugs Market Share by Type (2016-2027) Figure 54. Middle East & Africa Bronchiectasis Drugs Market Share by Application (2016-2027) Figure 55. Middle East & Africa Bronchiectasis Drugs Market Share by Country (2016-2027) Figure 56. Turkey Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Bronchiectasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Endo International Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021) Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021) Figure 61. Neopharma LLC Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021) Figure 62. Pfizer Inc. Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021) Figure 63. Reckitt Benckiser Group Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed
Endo International Plc GlaxoSmithKline Plc Neopharma LLC Pfizer Inc. Reckitt Benckiser Group Plc
Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that ina ... Read More
Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with curre ... Read More
Strict regulatory norms and increasing emphasis on developing safer vehicles have boosted the ado ... Read More
Vendors are making constant improvements in automotive steering systems by adding advanced featur ... Read More